INTERNATIONAL BIOTECHNOLOGY TRUST PLC
(the "Company")
The Company was notified on 12 January 2022 that Ms Kate Cornish-Bowden, a Non-Executive Director of the Company, purchased 1,500 Ordinary 25p shares in the capital of the Company at a price of 684.485 pence per Ordinary share. As a result of this purchase, Ms Kate Cornish-Bowden aggregate holding of shares in the Company is 9.500 Ordinary shares, representing 0.02% of the Company's issued share capital.
Notification of dealing form
1 |
Details of the person discharging managerial responsibilities / person closely associated |
||
a) |
Name |
Kate Cornish-Bowden |
|
2 |
Reason for the notification |
||
a) |
Position/status |
Non-Executive Director |
|
b) |
Initial notification /Amendment |
Initial notification |
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||
a) |
Name |
International Biotechnology Trust plc |
|
b) |
LEI |
213800N1QUJ744P76D11 |
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
a) |
Description of the financial instrument, type of instrument |
Ordinary shares |
|
Identification code |
GB0004559349 |
||
b) |
Nature of the transaction |
Share purchase |
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
684.485p |
1,500 |
||
d) |
Aggregated information
|
Aggregated price |
Aggregated volume |
N/A |
N/A |
||
e) |
Date of the transaction |
12 January 2022 |
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |